Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Smith, Matthew R, Saad, Fred, Chowdhury, Simon, Oudard, Stéphane, Hadaschik, Boris A, Graff, Julie N, Olmos, David, Mainwaring, Paul N, Lee, Ji Youl, Uemura, Hiroji, Lopez-Gitlitz, Angela, Trudel, Géralyn C, Espina, Byron M, Shu, Youyi, Park, Youn C, Rackoff, Wayne R, Yu, Margaret K, Small, Eric J
Published in The New England journal of medicine (12.04.2018)
Published in The New England journal of medicine (12.04.2018)
Get full text
Journal Article
Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)
Rathkopf, Dana E, Smith, Matthew R, de Bono, Johann S, Logothetis, Christopher J, Shore, Neal D, de Souza, Paul, Fizazi, Karim, Mulders, Peter F.A, Mainwaring, Paul, Hainsworth, John D, Beer, Tomasz M, North, Scott, Fradet, Yves, Van Poppel, Hendrik, Carles, Joan, Flaig, Thomas W, Efstathiou, Eleni, Yu, Evan Y, Higano, Celestia S, Taplin, Mary-Ellen, Griffin, Thomas W, Todd, Mary B, Yu, Margaret K, Park, Youn C, Kheoh, Thian, Small, Eric J, Scher, Howard I, Molina, Arturo, Ryan, Charles J, Saad, Fred
Published in European urology (01.11.2014)
Published in European urology (01.11.2014)
Get full text
Journal Article
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
DEMETRI, George D, CHAWLA, Sant P, LEBEDINSKY, Claudia, ELSAYED, Yusri A, IZQUIERDO, Miguel A, GOMEZ, Javier, PARK, Youn C, LE CESNE, Axel, VON MEHREN, Margaret, RITCH, Paul, BAKER, Laurence H, BLAY, Jean Y, HANDE, Kenneth R, KEOHAN, Mary L, SAMUELS, Brian L, SCHUETZE, Scott
Published in Journal of clinical oncology (01.09.2009)
Published in Journal of clinical oncology (01.09.2009)
Get full text
Journal Article
Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate-Treated Castration-Resistant Prostate Cancer Patients
Xu, Xu S, Ryan, Charles J, Stuyckens, Kim, Smith, Matthew R, Saad, Fred, Griffin, Thomas W, Park, Youn C, Yu, Margaret K, Vermeulen, An, Poggesi, Italo, Nandy, Partha
Published in Clinical cancer research (15.07.2015)
Published in Clinical cancer research (15.07.2015)
Get full text
Journal Article
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
Monk, Bradley J, Herzog, Thomas J, Kaye, Stanley B, Krasner, Carolyn N, Vermorken, Jan B, Muggia, Franco M, Pujade-Lauraine, Eric, Park, Youn C, Parekh, Trilok V, Poveda, Andres M
Published in European journal of cancer (1990) (01.10.2012)
Published in European journal of cancer (1990) (01.10.2012)
Get full text
Journal Article
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Fizazi, Karim, Tran, NamPhuong, Fein, Luis, Matsubara, Nobuaki, Rodriguez-Antolin, Alfredo, Alekseev, Boris Y, Özgüroğlu, Mustafa, Ye, Dingwei, Feyerabend, Susan, Protheroe, Andrew, De Porre, Peter, Kheoh, Thian, Park, Youn C, Todd, Mary B, Chi, Kim N
Published in The New England journal of medicine (27.07.2017)
Published in The New England journal of medicine (27.07.2017)
Get full text
Journal Article
Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis
Lebedinsky, Claudia, Gómez, Javier, Park, Youn C., Nieto, Antonio, Soto-Matos, Arturo, Parekh, Trilok, Alfaro, Vicente, Roy, Elena, Lardelli, Pilar, Kahatt, Carmen
Published in Cancer chemotherapy and pharmacology (01.11.2011)
Published in Cancer chemotherapy and pharmacology (01.11.2011)
Get full text
Journal Article
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Ryan, Charles J, Prof, Smith, Matthew R, Prof, Fizazi, Karim, Prof, Saad, Fred, Prof, Mulders, Peter F A, Prof, Sternberg, Cora N, MD, Miller, Kurt, Prof, Logothetis, Christopher J, Prof, Shore, Neal D, MD, Small, Eric J, Prof, Carles, Joan, MD, Flaig, Thomas W, MD, Taplin, Mary-Ellen, MD, Higano, Celestia S, Prof, de Souza, Paul, Prof, de Bono, Johann S, Prof, Griffin, Thomas W, MD, De Porre, Peter, MD, Yu, Margaret K, MD, Park, Youn C, PhD, Li, Jinhui, PhD, Kheoh, Thian, PhD, Naini, Vahid, PharmD, Molina, Arturo, MD, Rathkopf, Dana E, MD
Published in The lancet oncology (01.02.2015)
Published in The lancet oncology (01.02.2015)
Get full text
Journal Article
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Fizazi, Karim, Tran, NamPhuong, Fein, Luis, Matsubara, Nobuaki, Rodriguez-Antolin, Alfredo, Alekseev, Boris Y., Özgüroğlu, Mustafa, Ye, Dingwei, Feyerabend, Susan, Protheroe, Andrew, De Porre, Peter, Kheoh, Thian, Park, Youn C., Todd, Mary B., Chi, Kim N.
Published in The New England journal of medicine (27.07.2017)
Published in The New England journal of medicine (27.07.2017)
Get full text
Journal Article
Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer
Xu, Xu Steven, Ryan, Charles J., Stuyckens, Kim, Smith, Matthew R., Saad, Fred, Griffin, Thomas W., Park, Youn C., Yu, Margaret K., De Porre, Peter, Vermeulen, An, Poggesi, Italo, Nandy, Partha
Published in Clinical pharmacokinetics (2017)
Published in Clinical pharmacokinetics (2017)
Get full text
Journal Article
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
Harousseau, Jean-Luc, Martinelli, Giovanni, Jedrzejczak, Wieslaw W., Brandwein, Joseph M., Bordessoule, Dominique, Masszi, Tamas, Ossenkoppele, Gert J., Alexeeva, Julia A., Beutel, Gernot, Maertens, Johan, Vidriales, Maria-Belen, Dombret, Hervé, Thomas, Xavier, Burnett, Alan K., Robak, Tadeusz, Khuageva, Nuriet K., Golenkov, Anatoly K., Tothova, Elena, Mollgard, Lars, Park, Youn C., Bessems, Annick, De Porre, Peter, Howes, Angela J.
Published in Blood (06.08.2009)
Published in Blood (06.08.2009)
Get full text
Journal Article
Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial
Calvo, Emiliano, Azaro, Analia, Rodon, Jordi, Dirix, Luc, Huizing, Manon, Senecal, Francis Mark, LoRusso, Patricia, Yee, Lorrin, Poggesi, Italo, de Jong, Jan, Triantos, Spyros, Park, Youn C., Knoblauch, Roland E., Parekh, Trilok V., Demetri, George D., von Mehren, Margaret
Published in Investigational new drugs (01.06.2018)
Published in Investigational new drugs (01.06.2018)
Get full text
Journal Article
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy
Johnston, Stephen R. D., Semiglazov, Vladimir F., Manikhas, George M., Spaeth, Dominique, Romieu, Gilles, Dodwell, David J., Wardley, Andrew M., Neven, Patrick, Bessems, Annick, Park, Youn C., De Porre, Peter M., Perez Ruixo, Juan J., Howes, Angela J.
Published in Breast cancer research and treatment (01.07.2008)
Published in Breast cancer research and treatment (01.07.2008)
Get full text
Journal Article
PD27-01 EFFICACY AND LONG-TERM SAFETY ANALYSIS OF STUDY COU-AA-302: ABIRATERONE ACETATE PLUS PREDNISONE IN CHEMOTHERAPY-NAÏVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Shore, Neal, Rathkopf, Dana, Smith, Matthew R, de Bono, Johann S, Logothetis, Christopher, de Souza, Paul, Fizazi, Karim, Mulders, Peter F.A, Mainwaring, Paul, Hainsworth, John D, Beer, Tomasz M, North, Scott, Fradet, Yves, Griffin, Thomas, Park, Youn C, Kheoh, Thian, Small, Eric J, Scher, Howard I, Molina, Arturo, Ryan, Charles J
Published in The Journal of urology (01.04.2014)
Published in The Journal of urology (01.04.2014)
Get full text
Journal Article
Longer term preplanned efficacy and safety analysis of abiraterone acetate + prednisone (AA + P) in patients (pts) with newly diagnosed high-risk metastatic castration-naïve prostate cancer (NDx-HR mCNPC) from the phase 3 LATITUDE trial
Fizazi, Karim, Feyerabend, Susan, Matsubara, Nobuaki, Ozguroglu, Mustafa, Fein, Luis Enrique, Rodríguez Antolín, Alfredo, Alekseev, Boris Yakovlevich, Sulur, Giri, Protheroe, Andrew, De Porre, Peter, Li, Susan, Park, Youn C., Mundle, Suneel, Tran, Namphuong, Chi, Kim N.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Subsequent treatment after abiraterone acetate + prednisone (AA + P) in patients (pts) with newly diagnosed high-risk metastatic castration-naïve prostate cancer (NDx-HR mCNPC): Detailed analyses from the phase 3 LATITUDE trial
Chi, Kim N., Tran, Namphuong, Feyerabend, Susan, Matsubara, Nobuaki, Ozguroglu, Mustafa, Fein, Luis Enrique, Rodríguez Antolín, Alfredo, Alekseev, Boris Yakovlevich, Sulur, Giri, Protheroe, Andrew, De Porre, Peter, Li, Susan, Park, Youn C., Mundle, Suneel, Fizazi, Karim
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer
Fizazi, Karim, Tran, Namphuong, Fein, Luis Enrique, Matsubara, Nobuaki, Rodríguez Antolín, Alfredo, Alekseev, Boris Y., Ozguroglu, Mustafa, Ye, Dingwei, Feyerabend, Susan, Protheroe, Andrew, De Porre, Peter, Kheoh, Thian, Park, Youn C., Todd, Mary Beth, Chi, Kim N.
Published in Journal of clinical oncology (20.06.2017)
Published in Journal of clinical oncology (20.06.2017)
Get full text
Journal Article
LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer
Fizazi, Karim, Tran, Namphuong, Fein, Luis Enrique, Matsubara, Nobuaki, Rodríguez Antolín, Alfredo, Alekseev, Boris Y., Ozguroglu, Mustafa, Ye, Dingwei, Feyerabend, Susan, Protheroe, Andrew, De Porre, Peter, Kheoh, Thian, Park, Youn C., Todd, Mary Beth, Chi, Kim N.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Abiraterone acetate (AA) plus prednisone (P) 5 mg QD in metastatic castration-naïve prostate cancer (mCNPC): Detailed safety analyses from the LATITUDE phase 3 trial
Fizazi, Karim, Tran, Namphuong, Fein, Luis Enrique, Matsubara, Nobuaki, Bjartell, Anders, Galli, Luca, Lee, Jae-Lyun, Mazhar, Danish, North, Scott A., Olmos, David, Suttmann, Henrik, Zou, Qing, Li, Susan, Martin, Jason L., Park, Youn C., Sulur, Giri, Deprince, Kris, De Porre, Peter, Chi, Kim N.
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
SPARTAN, a phase 3 double-blind, randomized study of apalutamide (APA) versus placebo (PBO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC)
Small, Eric Jay, Saad, Fred, Chowdhury, Simon, Hadaschik, Boris A., Graff, Julie Nicole, Olmos, David, Mainwaring, Paul N., Uemura, Hiroji, Lopez-Gitlitz, Angela, Trudel, Geralyn Carol, Espina, Byron M., Shu, Youyi, Park, Youn C., Rackoff, Wayne R., Yu, Margaret K., Smith, Matthew Raymond
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article